Nicolas Leupin - 04 Mar 2026 Form 4 Insider Report for NovoCure Ltd (NVCR)

Signature
Steven Robbins, as attorney in fact for Leupin, Nicolas
Issuer symbol
NVCR
Transactions as of
04 Mar 2026
Net transactions value
-$14,636
Form type
4
Filing time
05 Mar 2026, 16:33:41 UTC
Previous filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Leupin Nicolas Former Chief Medical Officer C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE Steven Robbins, as attorney in fact for Leupin, Nicolas 05 Mar 2026 0002007766

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Sale $14,636 -1,100 -1.1% $13.31 102,979 04 Mar 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.